Drake & Associates, LLC Becton Dickinson & CO Transaction History

Drake & Associates, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$232.24 - $267.23 $26,939 - $30,998	-116 Reduced 6.58%	1,647 $401,000
Q3 2023 Oct 24, 2023	BUY	$254.9 - $283.59 $75,705 - $84,226	297 Added 20.26%	1,763 $455,000
Q2 2023 Jul 11, 2023	BUY	$238.39 - $265.32 $9,058 - $10,082	38 Added 2.66%	1,466 $387,000
Q1 2023 Apr 10, 2023	BUY	$229.71 - $259.35 $7,350 - $8,299	32 Added 2.29%	1,428 $353,000
Q4 2022 Jan 17, 2023	BUY	$218.29 - $256.91 $304,732 - $358,646	1,396 New	1,396 $0

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Drake & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Drake & Associates, LLC with notifications on news.